West Pharmaceutical Services, Inc.
WST
$251.38
$0.130.05%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.54% | 2.94% | 18.42% | -22.12% | -5.04% |
| Total Depreciation and Amortization | 15.48% | 6.97% | 6.43% | 12.36% | 13.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -130.95% | 202.50% | 1,042.86% | -126.32% | -110.69% |
| Change in Net Operating Assets | 247.66% | 2,200.00% | -129.08% | 100.29% | -12.64% |
| Cash from Operations | 32.09% | 9.49% | 7.33% | 9.48% | -20.49% |
| Capital Expenditure | 27.45% | 22.14% | 24.95% | 21.30% | 3.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 200.00% |
| Cash from Investing | 27.39% | 22.90% | 25.69% | 21.30% | 3.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -200.00% | 99.77% | 99.49% | 71.43% | 85.71% |
| Issuance of Common Stock | 48.39% | -33.33% | -23.53% | -73.81% | 0.00% |
| Repurchase of Common Stock | 99.63% | 99.81% | 99.73% | 50.07% | 69.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.27% | -4.14% | -3.42% | -3.40% | -3.38% |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | 83.02% | 82.14% | 93.17% | 45.76% | 63.64% |
| Foreign Exchange rate Adjustments | 97.80% | -132.43% | 1,781.82% | 197.70% | -256.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,684.13% | 165.77% | 167.80% | 68.11% | 85.91% |